West Paces Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$9.06M |
| 2 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.7M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.63M |
| 4 |
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
|
+$1.37M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$459K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Renasant Corp
RNST
|
+$539K |
| 2 |
Amgen
AMGN
|
+$223K |
| 3 |
3M
MMM
|
+$127K |
| 4 |
WEC Energy
WEC
|
+$115K |
| 5 |
Air Products & Chemicals
APD
|
+$111K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.2% |
| 2 | Financials | 6.37% |
| 3 | Consumer Discretionary | 5.7% |
| 4 | Healthcare | 4.76% |
| 5 | Industrials | 3.37% |
Similar funds
West Paces Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, West Paces Advisors held 476 positions worth $160M, up 12% from $143M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
West Paces Advisors deployed $12.5M of net new capital in Q2 2019, opening 5 new positions and adding to 26 existing holdings. Its largest new stake was RiverNorth Capital and Income Fund: 8,245 shares worth $165K.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 8.7% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Amgen, an estimated $223K trimmed.
- West Paces Advisors's largest Q2 2019 buy was RiverNorth Capital and Income Fund: 8,245 shares worth $165K.
- West Paces Advisors added most to iShares Core S&P Small-Cap ETF in Q2 2019, an estimated $9.06M increase.
- West Paces Advisors's biggest Q2 2019 reduction was Amgen, cutting an estimated $223K.
- West Paces Advisors fully exited Renasant Corp in Q2 2019, selling an estimated $539K.
- West Paces Advisors's ten largest holdings make up 50% of its $160M portfolio in Q2 2019.
- West Paces Advisors opened 5 new positions and closed 7 in Q2 2019.
- West Paces Advisors's portfolio value rose 12% quarter-over-quarter to $160M.
Based on West Paces Advisors's 13F filing for Q2 2019, filed 22 Dec 2023.